Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
AbbVie Expected To Ditch Abicipar After US FDA Setback
FDA determined that abicipar's benefit don't outweigh its risk of intraocular inflammation
More from New Products
More from Scrip